Update on the pathogenesis and treatment of systemic idiopathic arthritis.
about
Anakinra as an interleukin 1 receptor antagonist, complicated genetics and molecular impacts--from the point of view of mouse genomics.Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis.Effects of Differences in Lipid A Structure on TLR4 Pro-Inflammatory Signaling and Inflammasome Activation.Tocilizumab for the treatment of systemic juvenile idiopathic arthritis.Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis.New age of biological therapies in paediatric rheumatology.Republished: new age of biological therapies in paediatric rheumatology.Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome - effective treatment with tocilizumab.Serum amyloid A induces mitogenic signals in regulatory T cells via monocyte activation.The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.Assessment of vascular function in systemic onset juvenile idiopathic arthritis.Tumor necrosis factor-α -308 A/G gene polymorphism in children with juvenile idiopathic arthritis: relation to disease activity, damage, and functional status.IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry).
P2860
Q34081473-3B0E41FF-96BD-4CB0-AD6C-C1567E9FBF7DQ34771827-DD9F79F7-FC6B-4888-AC8E-A15BEE8334DCQ36029323-0F255FDD-ADAD-4E53-AF3A-2FEF20D9318DQ38044757-01D110B0-FAD9-4855-A7A4-8A7882F63944Q38087694-02DC3032-09A6-42BA-BA71-6BC785E4AC82Q38195363-C1FA28AF-7F88-41F2-ADB9-248B930F946AQ38250593-7FC610B6-22B7-499F-9760-2A02975F7983Q38648790-FD989305-8C77-4B6B-B4E0-4B290866FD34Q40696660-12946CDD-376B-4CF8-B111-9B5E1E32F211Q41072807-387313D8-1DBE-42EF-98F5-B8A2CE675611Q41840145-2B54A2EA-264D-4359-B194-57EDF87AB85AQ48827909-156D1178-409B-41F5-8EA7-F37BFDA14FB3Q50954037-169A3C3B-5610-4C53-BE03-31889F2271ACQ52330721-B54CCC61-75C4-4B00-9289-B5F81CC6DB7B
P2860
Update on the pathogenesis and treatment of systemic idiopathic arthritis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Update on the pathogenesis and treatment of systemic idiopathic arthritis.
@en
Update on the pathogenesis and treatment of systemic idiopathic arthritis.
@nl
type
label
Update on the pathogenesis and treatment of systemic idiopathic arthritis.
@en
Update on the pathogenesis and treatment of systemic idiopathic arthritis.
@nl
prefLabel
Update on the pathogenesis and treatment of systemic idiopathic arthritis.
@en
Update on the pathogenesis and treatment of systemic idiopathic arthritis.
@nl
P2860
P1476
Update on the pathogenesis and treatment of systemic idiopathic arthritis.
@en
P2093
Alexei A Grom
Keith A Sikora
P2860
P304
P356
10.1097/MOP.0B013E32834CBA24
P577
2011-12-01T00:00:00Z